AML NPM1 (without FLT3 ITD)

GeneTimepoints- on treatmentAdditional testsFollow-up post therapyNotes
NPM1 Bone marrow MRD- post cycle 2 and EoT  PB MRD sample post cycle 2BM 3 monthly for 2 years  or PB 2 monthly for 2 yearsPost #2 PB sample based on AML 17 and Dillon et al   *Recommendations based on Dillon et al. ELN recommends PB monitoring 4-6 weekly